Open Access
CC BY-NC-ND 4.0 · Journal of Fetal Medicine 2024; 11(03): 145-151
DOI: 10.1055/s-0044-1791262
Original Article

Placental Chorioangiomas: A Single Tertiary Center Experience

Authors

  • Zaneta Dias

    1   Department of Fetal Medicine, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India
  • Rinshi Elayedatt

    1   Department of Fetal Medicine, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India
  • Vivek Krishnan

    1   Department of Fetal Medicine, Amrita Institute of Medical Sciences, Ponekkara, Kochi, Kerala, India

Funding None.

Abstract

Background Chorioangiomas are benign vascular placental tumors. Although most of them remain small and are asymptomatic, large tumors (>4 cm) may cause maternal or fetal complications.

Methods We report seven cases of chorioangioma over a span of 8 years in a single tertiary center managed either conservatively or with necessary intervention. All cases were followed up and postnatal outcomes were recorded.

Results Six cases were diagnosed in the second trimester and one in the third trimester by ultrasound. Four were managed conservatively, while three of them required prenatal therapy: one interstitial laser and the other two an intrauterine arterial embolization of the feeder vessel. One underwent a rescue intrauterine fetal transfusion before definitive embolization. Conservatively managed patients developed gestational hypertension and growth restriction. They had low birth weight and needed neonatal intensive care. There was one intrauterine demise (IUD) and two healthy neonates in the cases that needed a fetal intervention.

Conclusion The management of chorioangioma is dynamic and challenging, ranging from conservative to prenatal intervention. Treatment failure can result in serious complications adversely affecting pregnancy outcomes. However, regular monitoring by ultrasound and Doppler surveillance with timely interventions can lead to good neonatal and maternal outcomes.

Consent to Participate and Consent to Publish

Written informed consent was obtained from the patients for participation and publication of this study.


Ethical Approval

This retrospective study was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Ethics Committee approved this study.


Author Contributions

All the authors contributed to the study's conception and design. All the authors have read and approved the final manuscript.




Publication History

Article published online:
26 September 2024

© 2024. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India